publication date: May. 11, 2018


Jane Reese-Coulbourne, advocate, consultant, industry executive, dies at 63

Jane Reese-Coulbourne

Jane Reese-Coulbourne


Jane Reese-Coulbourne, 63, a cancer patient advocate who moved into industry and science policy roles died of cancer on April 23.

Reese-Coulbourne was being treated at the Johns Hopkins Sidney Kimmel Cancer Center.

Reese-Coulbourne, a chemical engineer and a business consultant, was diagnosed with stage III breast cancer in her thirties. While being treated on protocol at NCI, she took part in forming the National Breast Cancer Coalition and its effort to gather 2.5 million signatures on a petition for a National Action Plan on Breast Cancer.

Reese-Coulbourne joined the NBCC staff, working for the advocacy group as an executive vice president between 1991 and 1998. She left for a job at NCI, where she worked as a consultant for five years.

Later, she worked with industry on expanded access issues, starting with helping set up access to the AstraZeneca drug Iressa before its approval by FDA. Later, she served as board chair of the Lung Cancer Alliance. Reese-Coulbourne’s parents died of lung cancer.

For six years starting in 2010, Reese-Coulbourne served as executive director of the Reagan-Udall Foundation for the Food and Drug Administration. At the foundation, she oversaw the start-up of a partnership funded by the Bill and Melinda Gates Foundation, working with WHO, FDA, EMA, and the Innovation in Medical Evidence Development and Surveillance program to support the development of … Continue reading Jane Reese-Coulbourne, advocate, consultant, industry executive, dies at 63

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.